Chronic allograft nephropathy uniformly affects recipients of cadaveric, nonidentical living-related, and living-unrelated grafts

Transplantation

Volumn 75, Issue 10, 2003, Pages 1677-1682

  Krieger, Nancy R ^a   Becker, Bryan N ^a   Heisey, Dennis M ^a   Voss, Barbara J ^a   D'Alessandro, Anthony M ^a   Becker, Yolanda T ^a   Odorico, Jon S ^a   Kalayoglu, Munci ^a   Pirsch, John D ^a   Sollinger, Hans W ^a   Knechtle, Stuart J ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BASILIXIMAB; CORTICOSTEROID; CREATININE; CYCLOSPORIN A; DACLIZUMAB; HLA B ANTIGEN; IMMUNOSUPPRESSIVE AGENT; MYCOPHENOLIC ACID; PREDNISONE; TACROLIMUS;

ADULT; ARTICLE; CADAVER KIDNEY; CHRONIC ALLOGRAFT NEPHROPATHY; CHRONIC KIDNEY DISEASE; CREATININE BLOOD LEVEL; CYTOMEGALOVIRUS INFECTION; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; NONBIOLOGICAL MODEL; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR;

ADULT; BIOPSY; CADAVER; CHRONIC DISEASE; FAMILY; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; RISK FACTORS; SURVIVAL ANALYSIS; TISSUE DONORS; TRANSPLANTATION, HOMOLOGOUS;

EID: 0038012540     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000063830.60937.06     Document Type: Article

References (42)

1. Cecka JM. The UNOS Scientific Renal Transplant Registry. In: Cecka JM, Terasaki PI, eds. Clinical transplants 2000. Los Angeles, UCLA Immunogenetics Center 2001, p 1.
2. Hariharan S, Johnson CP, Bresnaha BA, et al. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-612.
3. Racusen LC, Solez K, Colvin RB, et al. The Banff97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713-723.
4. Cecka JM, Terasaki PI. The UNOS scientific renal transplant registry. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1994. Los Angeles, UCLA Tissue Typing Laboratory 1995, p 1.
5. Hata Y, Ozawa M, Takemoto SK, et al. HLA matching. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1996. Los Angeles, UCLA Tissue Typing Laboratory 1997, p 381.
6. Zhou YC, Cecka JM. Effect of HLA matching on renal transplant survival. In: Terasaki PI, Cecka JM, eds. Clinical transplants 1993. Los Angeles, UCLA Tissue Typing Laboratory 1994, p 499.
7. Halloran PF, Melk A, Barth C. Rethinking chronic allograft nephropathy: The concept of accelerated senescence. J Am Soc Nephrol 1999; 10: 167-181.
8. Paul LC. Chronic allograft nephropathy: An update. Kidney Int 1999; 56: 783-793.
9. Pirsch JD, D'Alessandro AM, Sollinger HW, et al. The effect of donor age, recipient age, and HLA match on immunologic graft survival in cadaver renal transplant recipients. Transplantation 1992; 53: 55.
10. Takemoto SK, Cho YW, Gjertson DW. Transplant risks. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1999. Los Angeles, UCLA Immunogenetics Center 2000, p 325.
11. Matas AJ, Gillingham KJ, Payne WD, et al. The impact of an acute rejection episode on long-term renal allograft survival (t1/2). Transplantation 1994; 57: 857.
12. Leggat JE Jr, Ojo AO, Leichtman AB, et al. Long-term renal allograft survival: Prognostic implication of the timing of acute rejection episodes. Transplantation 1997; 63: 1268.
13. Monaco AP, Burke JF Jr, Ferguson RM, et al. Current thinking on chronic renal allograft rejection: Issues, concerns, and recommendations from a 1997 roundtable discussion. Am J Kidney Dis 1999; 33: 150.
14. Matas AJ. Chronic rejection: Definition and correlates. Clin Transplant 1994; 8: 162.
15. Kahan BD, Welsh M, Schoenberg L, et al. Variable oral absorption of cyclosporine: A biopharmaceutical risk factor for chronic renal allograft rejection. Transplantation 1996; 62: 599.
16. Almond PS, Matas A, Gillingham K, et al. Risk factors for chronic rejection in renal allograft recipients. Transplantation 1993; 55: 752.
17. Shoskes DA, Cecka JM. Deleterious effects of delayed graft function in cadaveric renal transplant recipients independent of acute rejection. Transplantation 1998; 66: 1697.
18. Ojo AO, Wolfe RA, Held PJ, et al. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997; 63: 968.
19. Cosio FG, Pelletier RP, Falkenhain ME, et al. Impact of acute rejection and early allograft function on renal allograft survival. Transplantation 1997; 63: 1611.
20. Terasaki PI, Gjertson DW, Cecka JM, et al. Fit and match hypothesis for kidney transplantation. Transplantation 1996; 62: 441.
21. Modena FM, Hostetter TH, Salahudeen AK, et al. Progression of kidney disease in chronic renal transplant rejection. Transplantation 1991; 52: 239.
22. Kasiske BL, Heim-Duthoy KL, Tortorice KL, et al. The variable nature of chronic declines in renal allograft function. Transplantation 1991; 51: 330.
23. Kasiske BL, Massy ZA, Guijarro C, et al. Chronic renal allograft rejection and clinical trial design. Kidney Int Suppl 1995; 52: S116.
24. Tilney NL. Chronic rejection and its risk factors. Transplant Proc 1999; 31: 41S.
25. Langle F, Sautner T, Grunberger T, et al. Impact of donor age on graft function in living-related kidney transplantation. Transplant Proc 1992; 24: 2725.
26. Brenner BM, Cohen RA, Milford EL. In renal transplantation, one size may not fit all. J Am Soc Nephrol 1992; 3: 162.
27. Almond PS, Matas AJ, Gillingham K, et al. Predictors of chronic rejection in renal transplant recipients. Transplant Proc 1993; 25: 936.
28. Troppmann C, Gillingham KJ, Benedetti E, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation: The multivariate analysis. Transplantation 1995; 59: 962.
29. Matas AJ, Gillingham KJ, Humar A, et al. Immunologic and nonimmunologic factors: Different risks for cadaver and living donor transplantation. Transplantation 2000; 69: 54.
30. Kerr SR, Gillingham KJ, Johnson EM, et al. Living donors age >55 years: To use or not to use. Transplantation 1999; 67: 999.
31. Cecka JM. The UNOS scientific registry. In: Cecka JM, Terasaki PI, eds. Clinical transplants 1998. Los Angeles, UCLA Tissue Typing Laboratory 1999, p 1.
32. Matas AJ. Chronic rejection in renal transplant recipients: Risk factors and correlates. Clin Transplant 1994; 8: 332.
33. Zeier M, Döhler B, Opelz G, et al. The effect of donor gender on graft survival. J Am Soc Nephrol 2002; 13: 2570.
34. Pirsch JD, D'Alessandro AM, Sollinger HW, et al. Living-unrelated renal transplantation at the University of Wisconsin. In: Terasaki PI, ed. Clinical transplants 1990. Los Angeles, UCLA Tissue Typing Laboratory 1991, p 241.
35. Ploeg RJ, Pirsch JD, Stegall MD, et al. Living unrelated kidney donation: An underutilized resource? Transplant Proc 1993; 25: 1532.
36. D'Alessandro AM, Pirsch JD, Knechtle SJ, et al. Living unrelated renal donation: The University of Wisconsin experience. Surgery 1998; 124: 604.
37. Haberal M, Gulay H, Tokyay R, et al. Living unrelated donor kidney transplantation between spouses. World J Surg 1992; 16: 1183.
38. Terasaki PI, Cecka JM, Gjertson DW, et al. High survival rates of kidney transplants from spousal and living unrelated donors. N Engl J Med 1995; 333: 333.
39. Smits JM, Persijn GG, DeMeester JM. Living unrelated renal transplantation: The new alternative? Transpl Int 1996; 9: 252.
40. Lowell JA, Brennan DC, Shenoy S, et al. Living-unrelated renal transplantation provides comparable results to living-related renal transplantation: A 12-year single-center experience. Surgery 1996; 119: 538.
41. Alfani D, Pretagostini R, Rossi M, et al. Analysis of 160 consecutive living unrelated kidney transplants: 1983-1997. Transplant Proc 1997; 29: 3399.
42. Binet I, Bock AH, Vogelbach P, et al. Outcome in emotionally related living kidney donor transplantation. Nephrol Dial Transplant 1997; 12: 1940.